AbbVie made a change atop its board of directors, naming CEO Robert Michael as chairman on Friday morning. The pharma giant announced that Michael will succeed Richard A. Gonzalez, the former CEO of ...

UBS analysts maintained a Buy rating for Alvotech SA (NASDAQ:ALVO) with a steady price target of $18.00, representing a 41% ...

AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume the additional position of chairman, effective July 1, ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in ...

Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...

Its Commercial Medicines Unit will then begin its procurement process for adalimumab, considering Humira as well as its biosimilar rivals. New contracts are then expected to be in place by ...

As pharmaphorum recently reported, the entrance of biosimilars to Humira is a significant event ... company’s executive director and biosimilar commercial lead, Stephen Pagnotta, noted is ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

In a Super Bowl commercial lineup that leaned into artificial intelligence, nonspecific meditations on divisiveness and the usual smattering of celebrities, Budweiser rose above the chaff with a ...

The ad cost an estimated $2 million for the Secret Service to produce, according to two sources familiar with the project — a hefty price tag that comes amid massive budget cuts and layoffs at ...